MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 70 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,541 | -30.5% | 3,870,547 | -0.7% | 0.00% | -25.0% |
| Q2 2023 | $26,692 | -7.2% | 3,896,498 | +5.5% | 0.00% | 0.0% |
| Q1 2023 | $28,773 | +2.6% | 3,693,494 | +0.3% | 0.00% | -20.0% |
| Q4 2022 | $28,031 | -99.9% | 3,683,430 | -2.1% | 0.01% | 0.0% |
| Q3 2022 | $30,747,000 | -39.4% | 3,763,386 | -28.3% | 0.01% | -16.7% |
| Q2 2022 | $50,759,000 | -32.3% | 5,249,135 | -1.9% | 0.01% | -25.0% |
| Q1 2022 | $75,020,000 | -11.4% | 5,350,923 | +29.0% | 0.01% | 0.0% |
| Q4 2021 | $84,680,000 | +22.3% | 4,146,919 | +31.8% | 0.01% | +14.3% |
| Q3 2021 | $69,262,000 | +13.0% | 3,146,934 | +15.0% | 0.01% | +16.7% |
| Q2 2021 | $61,277,000 | – | 2,737,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |